SCHEMBL32662010

SCHEMBL32662010

O=c1[nH]c2c(cc1CO)CCCC2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
KDM4E B2RXH2 4/20 0.57
HPGD P15428 4/20 0.57
HSD17B10 Q99714 3/20 0.57
NPSR1 Q6W5P4 2/20 0.51
GRIA1 P42261 1/20 0.41
GRIA2 P42262 1/20 0.41
GRIA3 P42263 1/20 0.41
GRIA4 P48058 1/20 0.41
HRH4 Q9H3N8 1/20 0.39
PARP1 P09874 1/20 0.39
ALOX15 P16050 3/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2747232 0.80 KDM4E (0.59) ALDH1A1KDM4EHPGDHSD17B10NPSR1
SCHEMBL22016185 0.80 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDHSD17B10NPSR1
SCHEMBL29198801 0.79 KDM4E (0.49) ALDH1A1KDM4EHPGDHSD17B10NPSR1
SCHEMBL32662205 0.77 GRIA1 (0.37) ALDH1A1KDM4EHPGDHSD17B10NPSR1
Hydrochloric Acid SCHEMBL30705688 0.75 KDM4E (0.49) ALDH1A1KDM4EHPGDHSD17B10NPSR1
SCHEMBL32662451 0.74 GRIA1 (0.35) ALDH1A1KDM4EHPGDHSD17B10GRIA1
SCHEMBL30705510 0.74 GRIA1 (0.35) ALDH1A1KDM4EHPGDHSD17B10GRIA1
SCHEMBL17675575 0.73 KDM4E (1.00) ALDH1A1KDM4EHPGDHSD17B10NPSR1
SCHEMBL4786314 0.72 ALDH1A1 (0.58) ALDH1A1KDM4EHPGDHSD17B10NPSR1
SCHEMBL14144727 0.72 KDM4E (0.58) ALDH1A1KDM4EHPGDHSD17B10NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260015337-A1 COMPOUNDS FOR TREATMENT A CORONAVIRUS INFECTION TRAWSFYNYDD THERAPEUTICS INC (US) 2026-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260015337-A1 COMPOUNDS FOR TREATMENT A CORONAVIRUS INFECTION ACE2, ACE, TMPRSS2 ALDH1A1 2439/4885KDM4E 3009/4885HPGD 1524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.